Celldex Therapeutics Inc (CLDX)
R&D to Revenue
307040.91%
Quarterly · Period ending:
CLDX R&D to Revenue
Latest reported307040.91%period ending
Latest reported307040.91%period ending
CLDX Quarterly R&D/Revenue (0.00% → 307040.91%)
Latest values, visible window
High-resolution chart · PNG
CLDX r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 658.8157% | |
| 462.9453% | |
| 1,227.2878% | |
| 2,139.5062% | |
| 1,275.3086% | |
| 1,181.5995% | |
| -13,162.4242% | |
| 633.3333% | |
| 211.1111% | |
| 633.3333% | |
| 145.4545% | |
| 450% | |
| 400% | |
| 275% | |
| 300% | |
| 1,300% | |
| 214.2857% | |
| 1,300% | |
| 533.3333% | |
| 1,500% | |
| 700% | |
| 250% | |
| 222.2222% | |
| 250% | |
| 166.6667% | |
| 166.6667% | |
| 140% | |
| 146.6667% | |
| 113.6364% | |
| 113.0435% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |